Nevertheless, the comparison of Progression-Free Survival (PFS) between these treatment modalities did not reach statistical significance (p>0.05).
← all excerpts
Early Recurrent Hepatocellular Carcinoma with CK19 Positive Receiving Transarterial Chemoembolization After Surgical Resection: A Novel Risk Model Study.
1
0.0500
0.0500